BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22679444)

  • 1. Electrostatic potential of human immunodeficiency virus type 2 and rhesus macaque simian immunodeficiency virus capsid proteins.
    Bozek K; Nakayama EE; Kono K; Shioda T
    Front Microbiol; 2012; 3():206. PubMed ID: 22679444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.
    Kono K; Song H; Yokoyama M; Sato H; Shioda T; Nakayama EE
    Retrovirology; 2010 Sep; 7():72. PubMed ID: 20825647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of a loop sequence between alpha-helices 6 and 7 of virus capsid (CA) protein in a human immunodeficiency virus type 1 (HIV-1) derivative that has simian immunodeficiency virus (SIVmac239) vif and CA alpha-helices 4 and 5 loop improves replication in cynomolgus monkey cells.
    Kuroishi A; Saito A; Shingai Y; Shioda T; Nomaguchi M; Adachi A; Akari H; Nakayama EE
    Retrovirology; 2009 Aug; 6():70. PubMed ID: 19650891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
    Ylinen LM; Keckesova Z; Wilson SJ; Ranasinghe S; Towers GJ
    J Virol; 2005 Sep; 79(18):11580-7. PubMed ID: 16140735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
    Wu F; Ourmanov I; Riddick N; Matsuda K; Whitted S; Plishka RJ; Buckler-White A; Starost MF; Hirsch VM
    J Virol; 2015 Feb; 89(4):2233-40. PubMed ID: 25473059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains.
    Wu F; Kirmaier A; White E; Ourmanov I; Whitted S; Matsuda K; Riddick N; Hall LR; Morgan JS; Plishka RJ; Buckler-White A; Johnson WE; Hirsch VM
    J Virol; 2016 Dec; 90(24):11087-11095. PubMed ID: 27681142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-sensitivity mutations in a Trim5-resistant primary isolate of pathogenic SIV identify two independent conserved determinants of Trim5α specificity.
    McCarthy KR; Schmidt AG; Kirmaier A; Wyand AL; Newman RM; Johnson WE
    PLoS Pathog; 2013 May; 9(5):e1003352. PubMed ID: 23675300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Human TRIM5α in Intrinsic Immunity.
    Nakayama EE; Shioda T
    Front Microbiol; 2012; 3():97. PubMed ID: 22435067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α.
    Miyamoto T; Yokoyama M; Kono K; Shioda T; Sato H; Nakayama EE
    PLoS One; 2011; 6(7):e22779. PubMed ID: 21829511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutant human immunodeficiency virus type 1 strains with high degree of resistance to cynomolgus macaque TRIMCyp generated by random mutagenesis.
    Sultana T; Nakayama EE; Tobita S; Yokoyama M; Seki Y; Saito A; Nomaguchi M; Adachi A; Akari H; Sato H; Shioda T
    J Gen Virol; 2016 Apr; 97(4):963-976. PubMed ID: 26795727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.
    Nakayama EE; Miyoshi H; Nagai Y; Shioda T
    J Virol; 2005 Jul; 79(14):8870-7. PubMed ID: 15994780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5α.
    Coren LV; Trivett MT; Jain S; Ayala VI; Del Prete GQ; Ohlen C; Ott DE
    Retrovirology; 2015 Feb; 12():11. PubMed ID: 25809491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simian immunodeficiency virus from the sooty mangabey and rhesus macaque is modified with O-linked carbohydrate.
    Stansell E; Canis K; Haslam SM; Dell A; Desrosiers RC
    J Virol; 2011 Jan; 85(1):582-95. PubMed ID: 20962077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue.
    Nakayama EE; Maegawa H; Shioda T
    Virology; 2006 Jun; 350(1):158-63. PubMed ID: 16647098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Three-Fold Axis of the HIV-1 Capsid Lattice Is the Species-Specific Binding Interface for TRIM5α.
    Morger D; Zosel F; Bühlmann M; Züger S; Mittelviefhaus M; Schuler B; Luban J; Grütter MG
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
    Kahl CA; Cannon PM; Oldenburg J; Tarantal AF; Kohn DB
    Gene Ther; 2008 Aug; 15(15):1079-89. PubMed ID: 18385767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration.
    Pizzato M; McCauley SM; Neagu MR; Pertel T; Firrito C; Ziglio S; Dauphin A; Zufferey M; Berthoux L; Luban J
    PLoS Pathog; 2015 Jul; 11(7):e1005050. PubMed ID: 26181333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
    Diaz-Griffero F; Kar A; Lee M; Stremlau M; Poeschla E; Sodroski J
    Virology; 2007 Dec; 369(2):400-10. PubMed ID: 17920096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection.
    Kono K; Song H; Shingai Y; Shioda T; Nakayama EE
    Virology; 2008 Apr; 373(2):447-56. PubMed ID: 18201746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species.
    Kirmaier A; Wu F; Newman RM; Hall LR; Morgan JS; O'Connor S; Marx PA; Meythaler M; Goldstein S; Buckler-White A; Kaur A; Hirsch VM; Johnson WE
    PLoS Biol; 2010 Aug; 8(8):. PubMed ID: 20808775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.